Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Retroviral integrations contribute to elevated host cancer rates during germline invasion

This article has been updated

Abstract

Repeated retroviral infections of vertebrate germlines have made endogenous retroviruses ubiquitous features of mammalian genomes. However, millions of years of evolution obscure many of the immediate repercussions of retroviral endogenisation on host health. Here we examine retroviral endogenisation during its earliest stages in the koala (Phascolarctos cinereus), a species undergoing germline invasion by koala retrovirus (KoRV) and affected by high cancer prevalence. We characterise KoRV integration sites (IS) in tumour and healthy tissues from 10 koalas, detecting 1002 unique IS, with hotspots of integration occurring in the vicinity of known cancer genes. We find that tumours accumulate novel IS, with proximate genes over-represented for cancer associations. We detect dysregulation of genes containing IS and identify a highly-expressed transduced oncogene. Our data provide insights into the tremendous mutational load suffered by the host during active retroviral germline invasion, a process repeatedly experienced and overcome during the evolution of vertebrate lineages.

Introduction

Retrovirus-like elements are abundant in vertebrate genomes1, comprising 8% of the human genome. They originate when exogenous retroviruses infect the host germline and are subsequently inherited by offspring as endogenous retroviruses (ERVs), some of which eventually reach fixation. Since most mammalian ERVs derive from germline infections that occurred millions of years ago, the early and most critical stages of host–pathogen accommodation, including the immediate effects on host health, remain unclear. Retroviruses are insertional mutagens, affecting the host in multiple potentially deleterious ways, including the disruption or alteration of gene expression2. This makes the transition from a newly endogenised, active retrovirus to a genomically fixed ERV a complex and dynamic evolutionary process. The ongoing conflict between virus and host (sometimes termed a retroviral “invasion” of the host germline), unfolds over millions of years, during which time proviruses can frequently reintegrate in the host genome causing further germline mutations (de facto natural mutagenesis). The proviruses will also undergo mutations which can ultimately render them inactive.

The negative effects of exogenous retroviral infection of somatic cells have been well characterised3,4. In addition, the consequences of retroviral germline infection, where proviruses in the germline (particularly gammaretroviruses) are subject to Mendelian inheritance and are potentially active in every cell of an individual, have been extensively studied in inbred and wild-derived laboratory mouse strains5. Indeed much of the variation between laboratory mouse strains is thought to be due to variation in the number and location of ERVs they possess5. Examples of interactions of ERVs with their host’s genome include the accumulation of new germline insertions6, the production of active virus infections triggering oncogenesis7 and in some cases recombination of defective ERVs to create new infectious viruses8.

Given the mutagenic nature of retroviruses, a general consequence of ongoing germline invasion is predicted to be increased host cancer rates but this has not yet been directly observed in outbred wild species7,8. Due to their oncogenic potential, it is likely that intact ERVs will be strongly selected against in favour of defective versions5. Evidence for such selection has recently been reported which shows that ERVs can be rapidly degraded through recombination during the early stages of germline invasion9. The host population will experience a greatly increased mutational burden overall until all proviral copies are attenuated.

The koala (Phascolarctos cinereus) provides a means of studying the early stages of retroviral endogenisation in a wild, outbred, large-bodied mammal. Koalas are currently undergoing active germline invasion, a process which likely began in the last 50,000 years10. This recent germline infection is in contrast to other species with unfixed ERVs, such as mice where the most recent ERV group (murine leukaemia virus, MLV) entered the genome ca. 1.5 million years ago11. The negative health effects on koalas caused by this invasion are also of interest and concern from a conservation perspective for this iconic and vulnerable species. The koala retrovirus (KoRV-A)12 is endogenous in all koalas from northern Australia, but some southern koalas are believed to remain unaffected as the virus has spread from north to south13. Other KoRV variants (designated KoRV-B through KoRV-I)14,15,16 have also been detected but are presumed to be exogenous (infecting only somatic cells and transmitted horizontally). Endogenous KoRV-A may also produce infectious virus particles and be spread horizontally as well as vertically13,17, though the evidence is correlative, and blocking of the receptor18 by endogenous KoRV-A may limit exogenous retroviral spread if it does occur in vivo.

KoRV is a member of a retroviral lineage associated with lymphoma and leukaemia19, both of which occur with remarkably high prevalence in koalas. In the wild, nearly 3% of mature northern koalas are affected by lymphoma20,21 (which is at least an order of magnitude higher than in humans) and over 7% suffer from lymphoid neoplasms21. In a study of captive koalas, 25% developed lymphoma, with a potential hereditary pattern of disease observed in some facilities22. Lymphoid neoplasms are associated with high KoRV viral loads and are seen at a higher rate in northern populations21,23. Many other benign and malignant tumours are also observed such as osteochondromas, which affect 2–4.5% of northern koalas20,21,22, mainly occurring in the skull and resulting in death through compression of organs.

Here, we show that northern koalas harbour ca. 80–100 inherited proviral copies in their germlines, none of which are fixed across the population and few of which are shared between individuals. Shared integration sites (IS) correspond to the geographical proximity of the koalas, and also suggest a possible KoRV-mediated predisposition to tumours. We find that tumour tissues accumulate somatic KoRV integrations which are significantly associated with genes involved in cancer. In one koala, we detect a KoRV provirus that has transduced a host oncogene, with the oncogene displaying markedly increased expression. Finally, we find genomic hotspots of KoRV integration in proximity to genes associated with cancer.

Results

Detection of KoRV IS in healthy and tumour tissue

We characterised KoRV IS in both tumour and healthy tissues from ten koalas from northern Australia. Details of the koalas, their diagnoses and the tissues used are provided in Supplementary Table 1. IS detection was carried out using a technique involving DNA sonication, inverse PCR (iPCR) and subsequent PacBio sequencing which we term SIP (for sonication iPCR)24. This generated long sequence reads (Supplementary Table 2) which span the regions of the koala genome flanking each IS and the adjoining proviral sequences (Supplementary Fig. 1). Mapping the reads to the koala genome (release version 4.1) allowed us to precisely identify the genomic position of each IS (Supplementary Fig. 2). A total of 1002 distinct IS were detected in the ten koalas (a full list is provided in Supplementary Data 1). Studies of KoRV have been facilitated by assembly of the koala genome25. Other more ancient ERVs are reported as rare in the koala genome (~1% of the genome) compared to other mammals, e.g. human, gorilla and mouse, where 8–12% of their genomes are composed of ancient ERVs. In general, Australian marsupials and monotremes are reported to contain a very low percentage of ERVs25, likely due to their geographical separation from species that act as retroviral reservoirs.

In each koala, the majority of IS were common to both healthy and tumour tissues (overall, 786 of the 1002 IS) (Fig. 1, Supplementary Table 3). The fact that most IS were independently identified in both healthy and tumour tissues indicates that IS detection using our SIP method24 was close to saturation. Moreover, all shared IS were found in both tissues of all koalas that shared the IS (if saturation had not been reached, IS would be missing in some tissues). Overall, false positives and negatives are unlikely to impact our findings (see Supplementary Figs. 13 for further details).

Fig. 1: Overview of IS detected in healthy and tumour tissues of ten koalas.
figure1

The name and sex of each koala is given, with age and year of birth in square brackets (age and year of birth are estimated from tooth wear). Number of IS detected in all tissues are shown in green for each koala and represent ERVs, whereas tumour-specific IS (shown in orange circles) represent somatic integrations in tumour tissues. Koalas sharing many IS are grouped (see Fig. 3), with the numbers of shared IS given in blue boxes (dark blue = total IS shared, including IS shared with other koalas; light blue = IS shared only between given koalas; lines connect koalas that share IS and do not represent specific family relationships). Outside of these groups, koalas share nine or fewer IS. Examples of genes containing IS shared only between indicated koalas are given (with genes containing IS in exons shown in boldface).

ERVs are present in all cells of an individual, being inherited in a Mendelian fashion. We found, on average, 100 KoRV ERVs per koala. This is in line with the number of KoRV proviruses found in the koala reference genome which has 98 KoRV ERVs, 65 of which are intact, full-length KoRV-A sequences26. Since the reference genome contains 65 intact copies of KoRV-A and KoRV genes are expressed in koalas27, it is plausible that some KoRV proviruses retain the potential to reintegrate (through reinfection or possibly retrotransposition), leading to further germline and/or somatic integrations. Therefore, in each of our koalas, some KoRV ERVs are likely to retain the ability to reintegrate and could potentially affect host gene expression. The majority of KoRV ERVs (79%) were not shared among the koalas examined. The lack of sharing of IS is reminiscent of inbred lab mouse strains where the formation of novel IS can occur, though at a very much lower rate than that seen in koalas28, but contrasts with older ERVs of vertebrates including those in humans which are generally found in all individuals at the same respective genomic loci. In koalas, the lack of fixed IS and the limited number of IS shared between individuals reflects the early stage of host germline invasion by KoRV and indicates a rapid expansion and accumulation of new IS across the northern koala population. It is not yet known whether new KoRV-A integrations are the result of (i) retroviral integration of a virus produced by an ERV in an individual; (ii) intracellular retrotransposition of an ERV; or (iii) new retroviral infection of an exogenous KoRV-A virus. However, in mice, active ERVs have been shown to produce infectious viruses from birth and generate new proviruses by infecting the oocytes of offspring in utero6.

KoRV-A and other KoRV variants were identified in our samples (Supplementary Table 4), with KoRV-A being by far the predominant subtype. Other subtypes are thought to be exogenous and thus present in a small proportion of host cells, so that KoRV-B, KoRV-D and KoRV-F represent only a tiny fraction of reads detected in any sample29. KoRV-B, which has been associated with cancer in a US zoo15, was found in only two of the koalas (Kathy and Butler) and therefore does not explain most of the observed neoplasms. Moreover, this variant of KoRV-B lacked the expanded repeats in the LTRs and the CETTG motif (shown to be more pathogenic than the CETAG/CGTAG motif present in KoRV-A) found in the zoo koalas. In this study, we have used the term KoRV to represent all insertions, recognising that nearly all IS in northern koalas are KoRV-A derived integrations, with a small number potentially arising from other KoRV variants.

Tumour-specific IS show an association with cancer genes

Of the 1002 IS characterised, 172 IS were detected exclusively in tumour tissues (“tumour-unique IS”) (Fig. 1). These are somatic integrations that are the result of retroviral genomic reintegration followed by clonal expansion of the tumour cells. The presence of tumour-specific IS was not attributable to sequence coverage differences (Supplementary Fig. 3), and the tumour specificity of a subset of these IS was verified by PCR (Supplementary Fig. 4). A further 37 IS were detected exclusively in healthy tissues which represent other non-cancer-related somatic reintegration events (14 of these occurred in a single koala, Kathy) (Supplementary Table 3).

Four koalas with malignant neoplasms showed an accumulation of IS in tumours, with over 20 tumour-specific IS each. Tumour-specific IS were found more often than expected in exons (Supplementary Fig. 5), although these were mainly non-coding exons (Supplementary Table 5), including the 5′ UTRs of cancer-related genes BCL2, IL6R, KRT13 and TRAF4. To investigate possible retroviral-mediated dysregulation of host genes, we selected the gene closest to each IS as a way to generate an unbiased gene set. Just under half (45.5%) of the 1002 IS are located within genes, and of the remainder, 74.5% are within 1 kb of a gene and 91% are within 50 kb. In each case, we determined the closest host gene, regardless of orientation. Although genes close to IS are the most likely to affected by retroviral-mediated dysregulation, longer range interactions and trans-interactions are possible30. The set of genes closest to tumour-specific IS were significantly enriched in KEGG pathways31 for cancer and Ras signalling, and in GO terms32 for leukocyte and lymphocyte differentiation (P< 0.05). There was also significant enrichment in disease gene sets (from DisGeNET33) related to leukaemia and lymphoma (P< 0.01), including proto-oncogenes such as BCL2 and MYC (Table 1, Supplementary Table 6). Tumour-specific IS also showed two-fold enrichments in three out of five cancer gene datasets (Supplementary Table 7). Enrichments were found even though many genes in koala are not yet fully annotated. The mechanisms which may bias the genomic positions of retroviral integration are complex; however, for gammaretroviruses such as KoRV it appears likely that regions of active transcription are particularly accessible to retroviral insertion34. Thus, while cancer-related genes are not necessarily preferential KoRV IS, they are transcriptionally active genes playing general roles in cellular homoeostasis, growth and proliferation and are therefore likely to be accessible for gammaretroviral integration. This IS preference is likely mediated by interactions between the viral integrase and host proteins (e.g. bromodomain and extraterminal domain proteins35). To examine whether there was a propensity for tumour-specific IS to be located near genes with higher expression, we used published RNA-seq data from koala lymph nodes36 and found a small but significant shift towards higher expression levels for the set of genes closest to tumour-specific IS (P= 0.005) (Supplementary Fig. 6). Furthermore, tumour development likely elicits a selection process favouring cells containing new, somatic KoRV IS that promote their propagation and survival in a similar way to what has been observed in MLV and HIV-1 infections37,38, leading to selection (clonal amplification) of IS in the vicinity of such genes.

Table 1 Gene enrichments for sets of genes closest to tumour-specific IS.

KoRV IS can dysregulate genes

To examine whether KoRV IS can induce gene dysregulation, we measured expression levels of genes containing tumour-specific IS in introns. We chose genes containing the highest coverage tumour-specific IS for testing (Supplementary Table 8 and Supplementary Fig 7). Using quantitative RT-PCR, we compared the expression of each gene in the tumour tissue of the koala with the IS to the same tissue type in other koalas lacking the IS. We used same tissue type to avoid among tissue variation in expression (likely to be greater than among animal variation) as a potential confounder. Gene expression could not be directly compared between healthy and tumour tissues in the same individual as distinct tissues were intentionally collected for each koala to ensure tumour-specific IS were identified (and some of the tumour types in this study were of diffuse phenotype meaning healthy matched tissue from the same organ was not available). Two additional zoo koalas were included as controls (Supplementary Table 9). These two koalas derived from a northern koala population and both died of old age (a reasonable control for the disease cohort with 40% aged animals). We found that for four of seven genes tested, expression was higher in the sample containing the tumour-specific IS compared to control tissues lacking the IS, indicating that the IS may be responsible for the change, with 4–97-fold increases (P< 0.05 for each comparison). Such changes in expression of proto-oncogenes are one mechanism by which KoRV integrations could promote tumourigenesis, malignant transformation and pro-metastasis pathways, consistent with other gammaretroviral driven expression changes38.

KoRV can transduce oncogenes

Retroviruses can acquire and transduce host genes (e.g. Rous sarcoma virus39, mouse gammaretroviruses8,40). We found evidence that this may be the case for KoRV. In one koala (Kathy), a KoRV sequence was identified in which the retroviral envelope gene was almost entirely replaced by the complete, in-frame coding sequence for the koala gene BCL2L1 (Fig. 2b, Supplementary Fig. 8). There are two known isoforms of BCL2L1, a long (Bcl-XL) and a short (Bcl-XS) form, which act as an apoptotic inhibitor41 and an apoptotic activator, respectively42. The fusion gene contained the long isoform, Bcl-XL, overexpression of which has been found to play a pivotal role in invasion of various malignant neoplasms in other species43. In Kathy, expression of BCL2L1 was found to be >500-fold greater than in other koalas (P = 0.00004) (Fig. 2a). Kathy suffered from anaplastic carcinoma of thyroid origin and copy number variants of BCL2L1 have been found in this cancer type44. The transduced KoRV also contained part of the 3′ UTR of the koala gene ZBTB18.

Fig. 2: qPCR expression of genes containing tumour-specific KoRV IS and structure of KoRV containing transduced oncogene.
figure2

a Expression of a set of genes containing tumour-specific IS. Quantitative PCR expression levels (∆∆Ct values83) are shown, per gene, for tumour tissue from the individual with the tumour-specific IS (square icon), and for tumour (triangles) or healthy tissues (circles) from other koalas (colour-coded). All qPCRs were performed in triplicate and the mean used for analysis. Boxplots indicate the interquartile range (IQR) with the centre line showing the median; whiskers show 1.5 × IQR. Two zoo koalas (Bilyarra and Mirali) not collected for the study of neoplasms were also used as controls, with Bilyarra used as a baseline for ∆∆Ct values (i.e. for each gene all ∆Ct values were divided by that of Bilyarra, so Bilyarra does not appear in the graph). Genes with significant changes in expression were: RASSF2 (P = 0.0023), RNF216 (P = 0.0096), KIF26B (P = 0.0015) and TIAM2 (P = 0.0425) based on t tests of ∆Ct values. The expression of the transduced oncogene BCL2L1 (Bcl-XL) shown on the right side of the graph was also significantly increased (P = 0.0004). The expression levels of BCL2L1 were 500-fold higher in Kathy than the other koalas tested (fold change calculated as 2−∆∆Ct). b Structure of the KoRV containing transduced BCL2L1 detected in Kathy. The two BCL2L1 exons are joined together precisely at the splice junction and are flanked by the beginning and end of the KoRV env gene. The BCL2L1 3′ UTR joins the 5′ and 3′ ends of env via micro-homologies (CAG and CCTCCC, respectively). Most of gag and pol are also replaced by a sequence similar to the 3′ UTR of koala gene ZBTB18.

We identified the IS associated with this transduced KoRV in Kathy and found six low coverage IS, five of which were specific to healthy tissue and one specific to tumour. This suggests multiple somatic integrations have occurred. Other somatic IS with very low read coverage may exist for the transduced KoRV, but these are difficult to detect. Overall, Kathy had the highest number of IS specific to healthy tissue (a total of 14), higher than the other koalas (which had from 0–5), indicating an abundance of somatic integrations in Kathy (Supplementary Table 3). The fact that the transduced KoRV has multiple, low coverage, tissue-specific integrations suggests that it may be exogenous. The variable parts of the LTRs and envelope protein that are used to define different KoRV strains are missing from the transduced KoRV, but the start of the LTR shows highest sequence identity to KoRV-A (98.5% across 203 bp).

We found some evidence that a similar gene transduction is also present in Elise at low titre. The gag gene of the transduced KoRV from Kathy also contained part of the 3′ UTR of the koala gene ZBTB18 and this sequence was also found within the gag gene in reads from Elise; however, the BCL2L1 sequence was not found in reads from Elise. Being one of the earliest collected samples, Elise had the shortest read lengths (due to DNA degradation over time) and so sequences at a greater distance from LTRs were less likely to be amplified during our iPCR procedure. Using primers specific to ZBTB18 and BCL2L1, we amplified the ZBTB18BCL2L1 spanning region in Elise (using other koalas as controls), and sequencing confirmed the presence of BCL2L1 although the junctions were not the same and this version appeared to be highly mutated compared to the version identified in Kathy (Supplementary Fig. 9). Although the data from Elise does not show that the transduced KoRV in Kathy is infectious, the low coverage, tissue-specific IS in Kathy suggest that the transduced virus may have been transmitted by infection. Further studies are required to confirm this. Although transduced retroviruses generally cannot promote infection by themselves due to loss of essential genes, they can be spread by infection using viral proteins produced by other intact proviruses within the cell39.

Shared ERVs near oncogenes may predispose koalas to cancer

Of 1002 IS identified, 793 were present in both healthy and tumour samples, and represent ERVs. Each koala carried 86–117 KoRV ERVs, some of which may have the potential to contribute to gene dysregulation throughout the life of the koala. The set of genes proximate to these IS was significantly enriched in two datasets of cancer genes (Supplementary Table 7), including cancer drivers (genes such as BRAF, PIK3R1, RELN and TIAM2) suggesting that some koalas may harbour ERVs that could confer increased cancer susceptibility. We also found that the top DisGeNet enrichment for this set of genes was for body mass index (P= 0.0034), indicating that ERVs are not as strongly associated with cancer genes as tumour-specific IS.

Endogenous IS are subject to gene flow and we found that 20% were present in more than one koala (Fig. 3a). All shared ERVs were found in both tissues of all koalas that shared the ERV, indicating the accuracy of ERV detection in our dataset. Only one IS was common to all of the koalas, located in an intron of the gene SLC29A1. This IS is also present in the koala reference genome. SLC29A1 is a highly conserved nucleoside transporter which also plays a role in the transport of xenobiotics45. SLC29A1-null mice have a significantly lower body weight than wild-type litter mates46 and low expression is associated with poor prognosis in patients with hepatocellular carcinoma47. Using published RNA-seq data36, we found that this gene had significantly higher expression in northern koalas compared to southern (Fig. 3b) suggesting that the intronic IS has an effect on expression of SLC29A1. The presence of this ERV in all koalas examined suggests that it does not have a highly detrimental effect. No other IS was shared to the extent of SLC29A1; other shared IS were present in no more than five koalas, and the majority of IS were unshared.

Fig. 3: Sharing of KoRV IS.
figure3

a Numbers of IS unique to one koala (either tumour-specific IS or IS in healthy tissue in a single koala) compared to those shared in PCA groups (shown in c). The single IS shared by ten koalas is located in the gene SLC29A1, an equilibrative nucleoside transporter. The three IS shared by five koalas were located 1 kb downstream of MAP4K4, in a 140 kb region between the genes CTNNBL1 and SRC, and in an intron of RCAN2. Insert shows percentages in the categories according to genomic location. Shared (other) refers to all IS shared between two or more koalas that are not in PCA groups. IS shared within the PCA groups are more likely to be in exons that those shared outside the groups. b From published RNA-seq data36, the expression of SLC29A1 in lymph nodes was found to be differentially expressed in northern koalas from Queensland (QLD) compared to koalas from South Australia (SA); this was the most significantly differentially expressed annotated gene between the two koala populations (using the Limma R package86 for differential expression analysis with false discovery rate used for multiple test correction: log fold change = 3.65, P = 1.35 × 10−5). Boxplots indicate the interquartile range (IQR) with the centre line showing the median; whiskers show 1.5 × IQR. c Sharing reflects the geographic proximity of the koalas with principle component analysis showing groups which correspond to proximity. Note: PCA analysis was carried out without prior knowledge of the geographic origin of each koala and led us to request the location data of the samples. d Provenance of the koalas shown on a map of coastal region bordering Queensland and New South Wales, Australia (~130 km north and south of Brisbane is shown). e Plot of number of shared IS versus geographical distance with pairs of koalas sharing the highest numbers of IS highlighted.

Principal component analysis and clustering identified groups of koalas based on shared IS (Fig. 3c, Supplementary Fig. 10). These groups corresponded to the geographic provenance of the koalas (Fig. 3d), with the number of shared IS decreasing exponentially with distance (a Mantel test demonstrated a strong negative correlation: r= −0.86; P= 0.0007 (Fig. 3e)). This is consistent with the fact that koalas do not generally disperse over large distances. Within these PCA groups, koalas shared up to 43 IS (mean = 26.8) compared to nine or fewer (mean = 4.3) outside the groups (Fig. 1). Also, within the groups, we found 4.9% of shared IS were located within an exon (mainly UTRs) (Supplementary Table 10), whereas only 1.1% of IS shared by geographically separated groups were located in exons (Fig. 3a) suggesting that IS within exons are less likely to propagate widely throughout the population. There was some correspondence between the PCA groupings of the koalas and the diagnosed tumour types, despite some koalas being collected up to 10 years apart. For example, koalas Ralf and Elise both suffered from lymphoma/leukaemia and shared an IS in the 5′ UTR of ZFAT, a gene implicated in hematopoietic malignancies47. This IS was also shared by the reference genome (a female koala named Bilbo). RNA-seq data exist for Bilbo from a study of chlamydial eye disease, and using these data, we examined gene expression around the IS in ZFAT in Bilbo and 29 other northern koalas. We found that Bilbo and two other koalas had markedly increased expression in ZFAT (~5–8-fold higher) (Supplementary Fig. 11). All three koalas were collected within a ~24 km geographic radius; Ralf and Elise were the only two of our samples to also originate in this area. The increase in gene expression was found to start exactly at the position of the IS and continue throughout the ZFAT gene suggesting that this IS increases expression of ZFAT. In another PCA grouping, all three koalas (Bonnie, Butler and Donovan) developed tumours in the head and neck and shared a single exonic IS in the 3′ UTR of LSAMP, a gene that is a candidate tumour suppressor in human osteosarcomas48. We hypothesise that inherited IS in or near proto-oncogenes could predispose affected individuals to certain cancers, but a larger dataset would be needed to confirm this. Overall, ERVs that have propagated widely throughout the koala population are less likely to have a negative effect on the health of koalas, but it is possible that deleterious ERVs are inherited within groups of related koalas, particularly when the detrimental effects occur after sexual maturity.

Hotspots of KoRV IS are located in regions containing known cancer genes

The complete set of 1002 IS detected were not distributed evenly across the genome and were found to be more often located within 10 kb of each other, at a frequency higher than expected by chance (17% of IS compared to 6.2% when positions were randomised maintaining same number of IS per scaffold, P < 0.0001). We used a Monte Carlo simulation method that has been previously described38 to determine the distribution of IS that would occur by random chance in various window sizes across the koala genome. The top seven regions of significant IS density are listed in Supplementary Table 11. These regions contain a total of 28 ERVs and 7 somatic IS. Three of these regions (Fig. 4) contained genes previously associated with cancer through insertional mutagenesis screens in mice (AHI149, PPFIBP150 and TM9SF251). In such mutagenesis screens, genes involved in tumour progression are detected by the presence of multiple, independent somatic IS, with transformation most frequently induced through dysregulation of gene expression by the viral promoters52. AHI1 expression is highly elevated in certain human lymphoma and leukaemia stem/progenitor cells53 and TM9SF2 has been linked leukaemia54. PPFIBP1 (liprin β1) interacts with metastasis-associated protein S100A455 and has been associated with tumour progression in patients with high-grade chondrosarcomas56 (a malignant transformation of osteochondroma). The other hotspot regions also contained genes associated with cancer, including SPOCK1 (Testican-1), which promotes growth, invasion and metastasis in several cancers57,58 including osteosarcoma59, and the proto-oncogenes MYB and MYC, which are frequently aberrantly expressed in leukaemias and lymphomas60,61. There were three independent integrations very close to the MYC transcription start site (clustered within 624 bp, within <1300 bp of MYC). Two of these were in healthy tissue and one was tumour specific. Therefore, it appears that IS with a high potential for inducing tumorigenesis can be present in all tissues. Since retroviral integrations can influence the transcriptional activity of nearby genes (on both strands), the hotspots of KoRV integration in regions containing cancer-related genes could be one factor predisposing koalas to developing tumours.

Fig. 4: Regions with significantly high IS density (hotspots) in the koala genome.
figure4

IS locations are shown with arrows. Regions longer than the identified hotspot windows are displayed to show the surrounding genes; locations of hotspots are indicated by thick back line on contig scale bar. Long non-coding RNAs are labelled “lnc” and genes without annotation are unlabelled. All regions contain multiple IS that are found in both healthy and tumour tissue (ERVs) (red arrows). Regions (ac) contain IS that are conserved in multiple koalas (purple arrows). Regions (a, d, e) contain tumour-specific IS (pink arrows). All regions contain genes with associations to cancer, namely a, TM9SF2; b, PPFIBP1; c, SPOCK1; d, AHI1 and MYB; e, MYC. There may also be positive benefits for increased expression of some genes in these regions; for example, a also contains a gene involved in vitamin metabolism (CLYBL), and the cancer genes PPFIBP1, SPOCK1 and AHI1 in regions bd, respectively, have roles in body weight and feeding behaviour. Two other identified hotspots are not shown here because they were not in close proximity to protein coding genes: one was surrounded by non-coding RNAs and the other was at the very start of a contig (see Supplementary Table 11).

In several of the hotspots, we found that the majority of koalas contained at least one IS within the region. For example, eight koalas had at least one IS in the dense region of IS upstream of CLYBL (Supplementary Fig. 12). Moreover, some of the hotspots contained IS that were widely shared among koalas, and so have been subject to inheritance unlike the somatic IS detected in mouse mutagenesis screens. It is possible that a small number of IS may be selected for favourable effects in early life, while also playing a role in tumour development at a later stage, a process known as antagonistic pleiotropy62. For example, the region with the most significant density of IS is located between the genes CLYBL, which is required for vitamin B12 metabolism63, and TM9SF2, which has been associated with leukaemia54. Other genes in hotspots that have cancer associations might also confer positive effects. For example, SPOCK1 and AHI1 have associations with obesity64,65 and feeding behaviour65 and PPFIBP1 plays an important role in the integrity of lymphatic vessels66, which are responsible for the uptake of dietary fat and fat-soluble vitamins. Since koalas have a nutritionally poor diet (eucalyptus), it is possible that KoRV IS, which upregulate genes involved in vitamin uptake or metabolism, and body weight or feeding behaviour could be beneficial even if there may be detrimental effects later in life.

Discussion

We provide insights into the ongoing retroviral invasion of the koala genome, focusing on the potential of KoRV to underlie the high cancer rates in the northern koala population. Using a method to accurately and comprehensively detect KoRV IS, we examined both tumour and healthy tissues from ten koalas, allowing us to detect KoRV ERVs and somatic integrations in tumour tissues. We find that northern koalas carry a high mutational burden from a rapid expansion and accumulation of endogenous KoRV integrations in the population. All koalas in the northern population likely carry similar numbers of KoRV-A proviruses67 with some proviral IS possibly conferring a higher cancer risk than others. It is also clear that this germline mutational load is compounded in individual koalas by substantial accumulation of somatic integrations. We find evidence that KoRV can induce gene dysregulation of proximate genes, both as an ERV and following somatic integrations. The inherited KoRV ERVs present in all tissues provide a pool of proviruses in every cell, from which new somatic integrations or gene transductions could potentially occur, with some somatic reintegration events potentially affecting oncogenes. KoRV-mediated dysregulation of oncogenes may cause cells to clonally expand resulting in our observed enrichment of tumour-specific integrations near oncogenes. In addition, we find that KoRV is able to transduce host oncogenes, potentially resulting in a transforming virus that could be transmissible, which would be of concern for koala conservation efforts. Although other factors may also contribute to cancer in koalas, the mutational burden from endogenous KoRV likely increases the frequency of tumorigenesis and may potentially shorten the time for cancer to develop (Fig. 5).

Fig. 5: Overview of KoRV transformation processes in koalas.
figure5

All northern koalas carry endogenous KoRVs (red koala images) which are subject to Mendelian inheritance (purple arrow). Having multiple potentially active ERVs in every cell, with reintegration (blue arrows) leading to additional IS in somatic cells (blue triangles), would confer a tremendous mutational load on the population. Both inherited and new somatic IS can potentially dysregulate oncogenes, leading to an increased risk of transformation, with additional new integrations occurring in the transformed population of cells promoting cancer and metastasis. The potential for KoRV to transduce oncogenes also increases cancer risk. Koalas without endogenous KoRV (grey koala images) will only develop cancers (at a much lower rate) through other mechanisms.

Koalas and KoRV represent one of the youngest germline invasion processes observed in mammals (<50,000 years) demonstrating the effects on the host at the earliest stages of the process, when the exogenous retroviruses and ERVs are biologically most similar. In most other mammalian species, ERVs are derived from germline invasions that occurred millions of years ago, so that host genomes now only contain ERVs that are fixed and inactive. A notable exception to this are MLVs in wild and laboratory mouse strains which remain capable of expression and replication even after ~1.5 million years within the host genome11. However, the variation in MLV insertion number, location and activity in mice is less than that of KoRV in koalas, probably reflecting, in part, the increased time frame of association of MLVs with their host. In species with much older ERVs (e.g. human ERVs68), the mutational load of these ERVs appears to be very low and few are linked to cancer in individuals.

In koalas, which have very high cancer rates for mammals, the KoRV-A induced mutational load should over time be purged, in part by their gradual degradation through mutation or recombination9, with degraded ERVs having a less detrimental impact on the health of the host. It is these degraded ERVs that are likely to persist and become fixed in the genome. However, koalas are at such an early stage in the endogenisation process10 that the tipping point at which the exogenous retroviral counterpart becomes extinct, degraded retroviruses cease to genomically proliferate, and subsequent genomic fixation occurs may not be reached for hundreds of thousands of years. Surviving retroviral endogenisation also involves the host genome accommodating the endogenous retroviral content or mitigating its effects, contributing to the evolution of host viral suppression mechanisms, for example, piRNAs69 or APOBEC3G70.

Overall, the newly endogenised retroviral content substantially affects the host genome in multiple ways, not only with strong selection pressure likely arising due to negative health effects but also with ERVs contributing new genomic sequence such as promoters, and even providing some beneficial effects71. This renders the evolutionary dynamics between virus and host complex. The profound evolutionary consequences of germline invasions have shaped vertebrate genomes and have been repeatedly experienced during vertebrate evolution, including the lineage leading to modern humans. However, the immediate health effects on a species, including increased cancer rates, must first be endured and overcome.

Methods

Sample collection

Koalas are a vulnerable species and northern koalas in particular suffer from multiple widespread diseases (e.g. KoRV related wasting, endemic chlamydia and cancer) and are also prone to injuries (dog attacks and road accidents) and so are regularly admitted to dedicated wildlife facilities for treatment and rehabilitation. The koalas included in this study were admitted to dedicated wildlife treatment and rehabilitation centres after being rescued from the wild for overt illness (e.g. large tumours, wasting). All treatment facilitates perform thorough and consistent veterinary examination and diagnostic procedures on all admissions. Note: koalas are given unique identification numbers at admission but are also commonly named for ease of identification by the veterinary team. After undergoing thorough diagnostic procedures under general anaesthetic performed by highly experienced wildlife veterinarians, koalas were diagnosed with advanced/untreatable neoplasia. Due to the serious and untreatable nature of their condition, koalas were humanely euthanised by the veterinary team via intravenous injection of pentobarbitone (0.5 ml/kg). After confirmation of death (listening for cessation of heartbeat), the koalas were promptly necropsied and tissue samples were collected during routine post mortem procedures by the onsite wildlife veterinarian. Individual tissues of interest were collected for histopathology (5–8 mm in size put into 10% buffered formalin) and immediate freezing (−80 °C) for later assessment.

Sample collections were conducted in accordance with the University of Queensland Animal Ethics Committee (approval no. MICRO/PARA/612/08/ARC).

DNA extraction and quantification

Overall, 30 mg of paired tumour and healthy tissue from each individual koala (Supplementary Table 1) was extracted using the Qiagen DNeasy® Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol with the following modifications: the tissue was lysed overnight for 15 h at 56 °C and hair was lysed for 48 h at 56 °C. The DNA concentration and quality was then determined using an Agilent Tapestation (Agilent Technologies USA) with Genomic ScreenTapes and reagents.

Shearing of DNA and circularisation of fragmented DNA

The genomic DNA for paired tumour and healthy tissues (Supplementary Table 1) was sheared to between 3 and 4 kb using the Covaris™ M220 with miniTUBE Blue. All extracted samples were fragmented using the following customised settings: intensity 0.1, 20% duty factor, 1000 cycles per burst, ten cycles at 20 s per cycle, temperature 20 °C. Where possible, 3 µg total DNA was fragmented and if not available, 1 µg total DNA was used in a final volume of 100 µl. To find the optimal ligation conditions for subsequent iPCR, we performed a series of ligations using a gradient of (total) input blunt ended DNA. This consisted of three gradient points (20, 40 and 60 ng of total DNA) representing concentrations of 0.2, 0.4 and 0.6 ng/μl run in triplicate 50 µl ligation reactions. Each ligation reaction was set up using a T4 DNA Ligase kit (5 U/µl) (Thermo Scientific) using 5 µl of T4 DNA ligase buffer (10X), 5 µl of 50% PEG 4000 solution, 2.5 µl of T4 DNA ligase and molecular biology grade water (Thermo Scientific). To reduce any sampling biases, each sample was diluted down to a concentration of 10 ng/μl (as per TapeStation readings) and the correct volume of DNA for each gradient point added accordingly. A circularisation (non-template) water blank was also run in triplicate for all samples. All circularisation reactions (samples and controls) were performed in triplicate and then pooled.

Inverse PCR

A total of 10 ng from each of the circularised gradient points was used as template for quadruplicate iPCR reactions. iPCR reactions were then performed on all paired healthy and tumour tissue samples (fragmented and circularised) using the following LTR primers: forward 5′-ATT TGC ATC CGG AGT TGT GT-3′ and reverse 5′-AGG GGC ACC CTA GAA ACT GT-3′. All primers are listed in Supplementary Table 12. Each primer contained a unique 6 bp barcode with additional three sacrificial nucleotide bases (to prevent loss of the barcode in case of limited DNAse activity) at the 5′ end to enable identification in case samples were later pooled for sequencing (although most samples were run in separate cells on a PacBio RSII machine). All samples and controls were amplified using the MyFi Mix (Bioline GmbH, Luckenwalde, Germany) using 50 µl of MyFi buffer (2X) and a final 0.4 µM concentration of each indexed primer in a 100 µl volume. Thermal cycling conditions were as follows: 95 °C for 1 min 30 s; followed by 30 cycles at 95 °C for 20 s, 57 °C for 30 s and 72 °C for 3 min. The iPCR products from the quadruplicate reactions were pooled for each gradient point and purified using the QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). Concentrations and DNA profiles were measured on the TapeStation and the optimal circularization product from all sample-amplified gradients (20, 40 or 60 ng) was selected by considering three criteria: (i) the DNA amount per microliter of iPCR product in the 2–7 kb range, (ii) the average length distribution between 600 bp and 7 kb range and (iii) the percentage of DNA within the 2–7 kb range. Only the optimal circularisation gradient point for each sample was used for PacBio sequencing.

PacBio sequencing

The purified iPCR products from the healthy and tumour tissues were processed by the Max Delbrück Center, Berlin, for PacBio library construction and sequencing. Samples were individually purified using AMPure XP beads (Beckman Coulter), at a concentration of 0.9X. Libraries were then created for each sample using the PacBio (Pacific Biosciences, Menlo Park, CA) 5 kb template preparation protocol and the SMRTbell™ Template Prep Kit 1.0 following the manufacturer’s guidelines. The length and concentration of the libraries were then determined with the 2100 Agilent Bioanalyzer using the 1200 DNA chemistry (Agilent Technologies). Sequencing on the PacBio RSII platform was performed using the MagBead Standard protocol, C4 chemistry and P6 polymerase on a single v3 Single-Molecule Real-Time (SMRT) cell with 1 × 180 min movie for each sample. Every sample was run across two Single-Molecule Real-Time (SMRT) cells to increase the coverage and an extra sequencing run was done for Elise tumour tissue (multiplexed with other samples) to further increase coverage. The reads from the insert sequence were processed within the SMRT® Portal browser (minimum full pass = 1; and a minimum predicted accuracy of 90).

Detecting IS from iPCR reads

Parts of the PacBio reads mapping to the KoRV-A or KoRV-B genomes (GenBank: AB72100.1 and KC779547.1, respectively) were identified using BLAST72 and removed so that only the koala genomic sequence surrounding the insertion sites remained. The published koala genome (P. cinereus release phaCin_unsw_v4.1, RefSeq assembly GCF_002099425.1) was also masked for KoRV sequences. The trimmed reads were aligned to the masked koala genome using BWA73 with the following parameters: BWA MEM –x pacbio –c 2500. The results were filtered using Samtools74 to remove reads that failed platform/vendor quality checks or were PCR duplicates. Matches longer than 50 bp with >90% identity to the koala genome were retained. Retroviral IS have a distinct coverage pattern from iPCR sequencing (Supplementary Fig. 2b). We used a stepwise approach whereby: (i) high coverage IS with at least ten reads on each side were identified (≥20× coverage at overlapping read starts/ends within a 10 bp window) and corresponding reads removed from the dataset; (ii) low coverage insertion sites (at least two reads on each side with at least five reads in total) were identified and corresponding reads removed from the dataset and (iii) one-sided IS (where IS had reads mapping only to either the upstream or downstream sequence) were identified from the remaining reads. The one-sided insertion sites were checked to see if there were both sides (a start and end) within 10 kb, indicating that the published koala genome also contained a KoRV at these positions or that there was an indel in the koala genome between these positions. The level of sequencing allowed us to reach almost full saturation of germline insertion sites in both tumour and healthy tissues (Supplementary Fig. 3).

Comparing tumour and healthy samples

For each koala, the coordinates of the IS from tumour tissue were compared to those from healthy tissue (using bedtools merge from the Bedtools suite75) to find IS unique to one tissue and IS common to both tissues. IS which overlapped or were within 10 bp of each (since the boundaries of the IS can vary slightly due to alignments) were annotated as the same IS. Scatter plots of insertion site coverage comparing tumour to healthy tissue in each koala were generated.

PCR to confirm tumour-specific IS

Seven of the highest coverage IS specific to tumour tissues were chosen for PCR confirmation. All primers are listed in Supplementary Table 12. The large number and generally high frequency of flanking sequences with large homopolymer stretches or skewed GC content precluded designing primers for many tumour-specific integrations. Primers were designed against the genomic region surrounding the IS (within 200 bp 5′ or 3′ of the IS). For each IS, one koala genome primer and one LTR primer was used in order to cross the IS (Supplementary Fig. 4a). The target sequence was amplified in the following reaction: 12.5 µl of MyTaq™ HS Mix (Bioline, USA), 3.5 µl of PCR grade water and 1.5 µl (10 mM) of IS specific primer and 1.5 µl (10 mM) or either forward (5′-ATT TGC ATC CGG AGT TGT GT-3′) or reverse LTR (5′- AGG GGC ACC CTA GAA ACT GT-3′) primers. The following thermocycling conditions were used: (i) 95 °C for 5 min; (ii) 35 cycles, with 1 cycle consisting of 95 °C for 20 s, 60 °C for 20 s and 72 °C for 1 min and (iii) 72 °C for 2 min. The resulting amplicons were Sanger sequenced at LGC Genomics (Germany) by primer walking and the sequences checked using BLAST72 to compare them to the expected IS and adjacent KoRV LTRs.

Detection of KoRV variants

The env gene sequences from the KoRV variants described in Chappell et al.14 (108 sequences from KoRV variants A, B, D, F, G, H, I) were downloaded from NCBI and the most highly variable section from the published sequence alignment was extracted (base 251 onwards). We used BLAST72 with an e-value cut-off of 0.001 and minimum match length of 90 bp to compare the variable region to all koala reads.

Annotation of insertion site locations and gene enrichment analyses

Bedtools closest from the Bedtools suite75 was used to annotate the location of each IS with reference to the koala transcriptome annotation (version 4.1). We took the closest gene to each IS, regardless of whether sense or antisense strand. The gene set was split into categories according to the category of the closest IS, namely: tumour unique; healthy unique (unique to a single koala) and shared. The position of IS relative to genes (distance 5′ or 3′, in exon, intron or UTR) was annotated.

We used Enrichr76,77 to detect any gene enrichments in KEGG pathways31 and OMIM and DisGeNET33 disease gene sets (using Fisher’s exact test). Since these enrichment analyses were carried out on human gene sets and not all human genes are annotated in koala, we repeated the analysis on DisGeNET to check for any bias as follows: the full DisGeNET gene sets were downloaded and only genes common to human and koala were selected. The tmod package in R was used to perform a hypergeometric test using the koala IS genes as the target set and the modified DisGeNET sets as the background. The disease enrichments and P values were compared to those from Enrichr and were found to be highly similar with the same top enrichments. GO Ontology enrichments were carried out using GOrilla78 using only genes common to human and koala in both target and background sets. We downloaded five databases of cancer genes: Bushman Lab Cancer Gene List (http://www.bushmanlab.org/links/genelists, v4 May 2018), harmonizome lymphoma79, Intogen80, DriverDB81 and The Cancer Gene Atlas (TCGA)82. We used these to detect cancer gene enrichments in the sets of genes closest to healthy tissue IS and tumour-specific IS. For genes from TCGA (variants across 10,000 patients in 33 cancer types), only genes with variants found in > 500 individuals were used.

RNA Extraction and cDNA synthesis for quantitative PCR (qPCR)

Overall, 30 mg of paired tumour and healthy tissue from each individual koala was extracted using Qiagen RNeasy® Mini Kit (Qiagen, Hilden, Germany) with the RNase-Free DNase Set. The following modifications were made to the manufacturer’s protocol: tissues were lysed using 600 µl RTL buffer and the Precellys 24 Tissue Homogenizer. cDNA was then generated from the extracted rRNA using the Invitrogen SuperScript® IV Kit (Thermo Fisher Scientific, USA) following the manufacturer’s instructions; two reactions per sample were performed. Second strand synthesis was then carried out by adding 1 µl of Klenow DNA polymerase I (Thermo Fisher Scientific, USA) to 21 µl of cDNA and incubated at 37 °C for 60 min followed by 75 °C for 20 min. The cDNA was the quantified using the Agilent Tapestation (Agilent Technologies, USA) using D1000 ScreenTapes and reagents.

Selecting genes for qPCR

From the six koalas that had available tissue for expression analysis, we chose the three koalas with the largest numbers of tumour-specific insertion sites for qPCR analysis. The list of IS was ordered by the read coverage (as very low coverage may indicate that the insertion site is not in many cells in the tissue). Insertion sites were excluded if only one side of the insertion site was covered by reads. We selected genes where the insertion site was in an intron (as we make the assumption that this gene will be most affected by any promoter effects). We excluded genes which had putative annotations or were of unknown function.

To choose regions for primer design, we used the koala transcriptome annotation to select consecutive exons that were present in all predicted transcript variants of each gene to avoid alternative splicing events. In case of any errors in the koala genome annotation, we used Blastx to compare these exons to the SWISSPROT/TREMBL database to select exons which are conserved in other species at the protein level. Forward and reverse primers were placed in consecutive exons.

Gene expression using qPCR

To assess gene expression levels, SYBR green based comparative CT (ΔΔCT) and qPCR were employed. Koalas selected were those that had tissue samples from liver and/or lymph node so that expression levels could be measured in the same tissue between koalas. Two additional koalas from outside this study (Bilyarra and Mirali) were also included as controls. Expression levels of seven genes in healthy and tumour tissues were assessed. The samples tested in each case were: (i) tumour tissue from koala with IS in gene of interest; (ii) tumour tissue from koalas without IS in gene of interest and (iii) healthy tissue. Primer concentrations were optimised according to the manufacturer’s protocol. All primers are listed in Supplementary Table 12. Overall, 100 ng of cDNA from both tumour and healthy tissues were run in triplicate reactions for each primer set in addition to negative controls and housekeeping gene controls. The target gene was amplified using the following reaction: 0.5 µM of the forward and reverse primer, 12.5 µl SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich, USA), 0.25 µl reference dye (ROX) and 10 µl of template cDNA. The PCR was carried out in 96-well plates using the Stratagene MX3000P System (Agilent Technologies, USA) and StepOnePlus instruments under the following cycling conditions: 94 °C for 2 min, followed by 40 cycles, with 1 cycle consisting of 94 °C for 15 s and 60 °C for 1 min. GAPDH was run as a housekeeping gene. For all koalas, ∆CT were calculated by subtracting the CT value of GAPDH from the test gene CT value. Gene expression values were normalised (∆∆CT) by subtracting the ∆CT of Bilyarra’s healthy tissues. The fold difference was then taken as 2−∆∆CT83.

Analysis of shared IS

PCA was performed on a matrix of IS versus koalas for all IS in healthy tissues using the R package logisticPCA for dimensionality reduction of binary data. Clustering was performed using hclust in R with a binary distance matrix. Geographic distances between koalas were calculated as the shortest straight line between locations. A Mantel test of distance versus number of shared IS was performed in R using the ade4 library.

Expression of SLC29A1 and ZFAT

Data were downloaded from the European Read Archive (Project numbers PRJEB21505 and PRJEB26467, respectively). Reads were trimmed using BBduk from BBTools (https://sourceforge.net/projects/bbmap/) and aligned to the koala reference genome (RefSeq assembly GCF_002099425.1) using STAR84. Reads were counted using htseq-count85 and differential expression was analysed using the R package Limma86, with sex and disease status included as factors in the model. As a further check for SLC29A1, the expression was normalised using the expression of the housekeeping gene GAPDH in the samples but the difference in expression between northern and southern koalas remained.

Retrovirus transduction discovery

The transduced BCL2L1 was discovered because reads mapping to this gene had an unusual coverage pattern where the reads mapped precisely to the exons, ending at the exon boundaries. From the full-length reads, the fusion of BCL2L1 within the KoRV env gene was apparent and, additionally, a fragment of the 3′ UTR of the gene ZBTB18 was also detected in the gag gene. All koala samples were subsequently searched for this fusion using BLAST and six koalas (Elise, Lisa, Bonnie, Ralf, A30038 and A31756) were checked using PCR. All primers are listed in Supplementary Table 12. The band from PCR of Elise was Sanger sequenced.

All samples were also scanned for any other reads which mapped precisely to exons, but none were found. Integrations sites for the transduced virus were identified by selecting the reads containing to the BCL2L1 fusion and removing any parts matching the BCL2L1 fusion sequence. BLAST72 was used to find where the remaining parts of the reads mapped in the koala genome.

Distribution of IS in koala genome

To assess if IS were distributed in a random fashion, we performed 1000 randomizations of IS coordinates using bedtools shuffle75 and calculated the numbers of IS located within 10 kb. We then performed a chi-squared test for 2 × 2 contingency tables comparing real IS to random IS on number of single IS in 10 kb compared with number of two or more IS within 10 kb.

Finding statistically significant hotspots of IS

We implemented a Monte Carlo simulation following a method used to find common insertion sites in a retroviral tagging study38. We used bedtools shuffle75 to generate 10,000 randomisations of the IS across the koala genome. For windows of varying sizes (2, 10, 30, 50, 100, 200, 300 and 400 kb), we counted the number windows containing a given number of IS (2–10). Also, since a random distribution of IS in the genome follows a Poisson distribution, we calculated the Poisson probability for each window size containing two or more IS and corrected for number of windows tested.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

Sequence data that support the findings of this study are deposited in the NCBI Short Read Archive under BioProject PRJNA587467. The remaining data are available within the article, Supplementary Information or available from the authors upon request.

Change history

  • 12 April 2021

    Open Access funding information has been added to this article.

References

  1. 1.

    Lee, A., Nolan, A., Watson, J. & Tristem, M. Identification of an ancient endogenous retrovirus, predating the divergence of the placental mammals. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368, 20120503 (2013).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  2. 2.

    Sokol, M., Wabl, M., Ruiz, I. R. & Pedersen, F. S. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors. Retrovirology 11, 36 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  3. 3.

    Biswas, H. H. et al. Increased all-cause and cancer mortality in HTLV-II infection. J. Acquir. Immune Defic. Syndr. 54, 290–296 (2010).

    PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Tsatsanis, C. et al. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J. Virol. 68, 8296–8303 (1994).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Nellaker, C. et al. The genomic landscape shaped by selection on transposable elements across 18 mouse strains. Genome Biol. 13, R45 (2012).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  6. 6.

    Richoux, V., Panthier, J. J., Salmon, A. M. & Condamine, H. Acquisition of endogenous ecotropic MuLV can occur before the late one-cell stage in the genital tract of SWR/J-RF/J hybrid females. J. Exp. Zool. 252, 96–100 (1989).

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Holt, M. P., Shevach, E. M. & Punkosdy, G. A. Endogenous mouse mammary tumor viruses (mtv): new roles for an old virus in cancer, infection, and immunity. Front. Oncol. 3, 287 (2013).

    PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Stoye, J. P., Moroni, C. & Coffin, J. M. Virological events leading to spontaneous AKR thymomas. J. Virol. 65, 1273–1285 (1991).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Lober, U. et al. Degradation and remobilization of endogenous retroviruses by recombination during the earliest stages of a germ-line invasion. Proc. Natl Acad. Sci. USA 115, 8609–8614 (2018).

    ADS  PubMed  Article  CAS  Google Scholar 

  10. 10.

    Ishida, Y., Zhao, K., Greenwood, A. D. & Roca, A. L. Proliferation of endogenous retroviruses in the early stages of a host germ line invasion. Mol. Biol. Evol. 32, 109–120 (2015).

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Stocking, C. & Kozak, C. A. Murine endogenous retroviruses. Cell Mol. Life Sci. 65, 3383–3398 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Tarlinton, R. E., Meers, J. & Young, P. R. Retroviral invasion of the koala genome. Nature 442, 79–81 (2006).

    ADS  CAS  PubMed  Article  Google Scholar 

  13. 13.

    Simmons, G. S. et al. Prevalence of koala retrovirus in geographically diverse populations in Australia. Aust. Vet. J. 90, 404–409 (2012).

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Chappell, K. J. et al. Phylogenetic diversity of koala retrovirus within a wild koala population. J. Virol. 91, e01820–16 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Xu, W. et al. An exogenous retrovirus isolated from koalas with malignant neoplasias in a US zoo. Proc Natl Acad Sci USA 110, 11547–11552 (2013).

    ADS  CAS  PubMed  Article  Google Scholar 

  16. 16.

    Shojima, T. et al. Identification of a novel subgroup of koala retrovirus from koalas in Japanese zoos. J. Virol. 87, 9943–9948 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Quigley, B. L., Ong, V. A., Hanger, J. & Timms, P. Molecular dynamics and mode of transmission of koala retrovirus as it invades and spreads through a wild Queensland koala population. J. Virol. 92, e01871–17 (2018).

    PubMed  PubMed Central  Google Scholar 

  18. 18.

    McDougall, A. S. et al. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J. Virol. 68, 2151–2160 (1994).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Hanger, J. J., Bromham, L. D., McKee, J. J., O’Brien, T. M. & Robinson, W. F. The nucleotide sequence of koala (Phascolarctos cinereus) retrovirus: a novel type C endogenous virus related to gibbon ape leukemia virus. J. Virol. 74, 4264–4272 (2000).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Gonzalez-Astudillo, V. et al. A necropsy study of disease and comorbidity trends in morbidity and mortality in the koala (Phascolarctos cinereus) in South-East Queensland, Australia. Sci. Rep. 9, 17494 (2019).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Fabijan, J. et al. Pathological findings in koala retrovirus-positive koalas (Phascolarctos cinereus) from Northern and Southern Australia. J. Comp. Pathol. 176, 50–66 (2020).

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Gillett, A. K. An examination of disease in captive Australian koalas (Phascolarctos cinereus) and potential links to koala retrovirus (KoRV). Tech. Rep. Aust. Mus. Online 24, 39–45 (2014).

    Article  Google Scholar 

  23. 23.

    Sarker, N. et al. Koala retrovirus viral load and disease burden in distinct northern and southern koala populations. Sci. Rep. 10, 263 (2020).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Alquezar-Planas, D. E. et al. DNA sonication inverse PCR for genome scale analysis of uncharacterized flanking sequences. Methods Ecol. Evol. 12, 182–195 (2020).

    Article  Google Scholar 

  25. 25.

    Johnson, R. N. et al. Adaptation and conservation insights from the koala genome. Nat. Genet. 50, 1102–1111 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Hobbs, M. et al. Long-read genome sequence assembly provides insight into ongoing retroviral invasion of the koala germline. Sci. Rep. 7, 15838 (2017).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  27. 27.

    Hobbs, M. et al. A transcriptome resource for the koala (Phascolarctos cinereus): insights into koala retrovirus transcription and sequence diversity. BMC Genom. 15, 786 (2014).

    Article  Google Scholar 

  28. 28.

    Jenkins, N. A. & Copeland, N. G. High frequency germline acquisition of ecotropic MuLV proviruses in SWR/J-RF/J hybrid mice. Cell 43, 811–819 (1985).

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Quigley, B. L. et al. Changes in endogenous and exogenous koala retrovirus subtype expression over time reflect koala health outcomes. J. Virol. 93, e00849–19 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Babaei, S., Akhtar, W., de Jong, J., Reinders, M. & de Ridder, J. 3D hotspots of recurrent retroviral insertions reveal long-range interactions with cancer genes. Nat. Commun. 6, 6381 (2015).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Pinero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45, D833–D839 (2017).

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Desfarges, S. & Ciuffi, A. Retroviral integration site selection. Viruses 2, 111–130 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Sharma, A. et al. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc. Natl Acad. Sci. USA 110, 12036–12041 (2013).

    ADS  CAS  PubMed  Article  Google Scholar 

  36. 36.

    Sarker, N. et al. Identification of stable reference genes for quantitative PCR in koalas. Sci. Rep. 8, 3364 (2018).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Maldarelli, F. et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345, 179–183 (2014).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Suzuki, T. et al. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32, 166–174 (2002).

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Swanstrom, R., Parker, R. C., Varmus, H. E. & Bishop, J. M. Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc. Natl Acad. Sci. USA 80, 2519–2523 (1983).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Ruscetti, S. K. Deregulation of erythropoiesis by the Friend spleen focus-forming virus. Int J. Biochem. Cell Biol. 31, 1089–1109 (1999).

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Boise, L. H. et al. Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597–608 (1993).

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Schott, A. F., Apel, I. J., Nunez, G. & Clarke, M. F. Bcl-X(L) protects cancer-cells from P53-mediated apoptosis. Oncogene 11, 1389–1394 (1995).

    CAS  PubMed  Google Scholar 

  43. 43.

    Trisciuoglio, D. et al. BCL-XL overexpression promotes tumor progression-associated properties. Cell Death Dis. 8, 3216 (2017).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  44. 44.

    Kasaian, K. et al. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy. BMC Cancer 15, 984 (2015).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  45. 45.

    Klaassen, C. D. & Lu, H. Xenobiotic transporters: ascribing function from gene knockout and mutation studies. Toxicol. Sci. 101, 186–196 (2008).

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Choi, D. S. et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat. Neurosci. 7, 855–861 (2004).

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Tsunoda, T. & Shirasawa, S. Roles of ZFAT in haematopoiesis, angiogenesis and cancer development. Anticancer Res. 33, 2833–2837 (2013).

    CAS  PubMed  Google Scholar 

  48. 48.

    Kresse, S. H. et al. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes Chromosomes Cancer 48, 679–693 (2009).

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Jiang, X. et al. Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia. Blood 103, 3897–3904 (2004).

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Johansson, F. K., Goransson, H. & Westermark, B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24, 3896–3905 (2005).

    CAS  PubMed  Article  Google Scholar 

  51. 51.

    Clark, C. R. et al. Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci. Rep. 8, 15327 (2018).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  52. 52.

    Touw, I. P. & Erkeland, S. J. Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia. Mol. Ther. 15, 13–19 (2007).

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Ringrose, A. et al. Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia 20, 1593–1601 (2006).

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Erkeland, S. J. et al. Large-scale identification of disease genes involved in acute myeloid leukemia. J. Virol. 78, 1971–1980 (2004).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Kriajevska, M. et al. Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J. Biol. Chem. 277, 5229–5235 (2002).

    CAS  PubMed  Article  Google Scholar 

  56. 56.

    Rozeman, L. B. et al. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. Cancer 107, 380–388 (2006).

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Li, Y. et al. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. Gastroenterology 144, 179–191 (2013).

    CAS  PubMed  Article  Google Scholar 

  58. 58.

    Shu, Y. J. et al. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Mol. Cancer 14, 12 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. 59.

    Wang, Y., Wang, W. & Qiu, E. SPOCK1 promotes the growth of osteosarcoma cells through mTOR-S6K signaling pathway. Biomed. Pharmacother. 95, 564–570 (2017).

    CAS  PubMed  Article  Google Scholar 

  60. 60.

    Slack, G. W. & Gascoyne, R. D. MYC and aggressive B-cell lymphomas. Adv. Anat. Pathol. 18, 219–228 (2011).

    PubMed  Article  Google Scholar 

  61. 61.

    Nakano, K., Uchimaru, K., Utsunomiya, A., Yamaguchi, K. & Watanabe, T. Dysregulation of c-Myb pathway by aberrant expression of proto-oncogene MYB provides the basis for malignancy in adult T-cell leukemia/lymphoma cells. Clin. Cancer Res. 22, 5915–5928 (2016).

    CAS  PubMed  Article  Google Scholar 

  62. 62.

    Carter, A. J. & Nguyen, A. Q. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med. Genet. 12, 160 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    Shen, H. et al. The human knockout gene CLYBL connects itaconate to vitamin B12. Cell 171, 771–B782 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  64. 64.

    Lecube, A. et al. Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity. J. Neuroendocrinol. 24, 944–952 (2012).

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Wang, H. et al. Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor. J. Biol. Chem. 287, 2237–2246 (2012).

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Norrmen, C. et al. Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity. Blood 115, 906–909 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Zheng, H. et al. Koala retrovirus diversity, transmissibility, and disease associations. Retrovirology 17, 34 (2020).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Subramanian, R. P., Wildschutte, J. H., Russo, C. & Coffin, J. M. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8, 90 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  69. 69.

    Yu, T. et al. The piRNA response to retroviral invasion of the koala genome. Cell 179, 632–643 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Ito, J., Gifford, R. J. & Sato, K. Retroviruses drive the rapid evolution of mammalian APOBEC3 genes. Proc. Natl Acad. Sci. USA 117, 610–618 (2020).

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Dunn-Fletcher, C. E. et al. Anthropoid primate-specific retroviral element THE1B controls expression of CRH in placenta and alters gestation length. PLoS Biol. 16, e2006337 (2018).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  72. 72.

    Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  73. 73.

    Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  74. 74.

    Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  75. 75.

    Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  76. 76.

    Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).

    Article  Google Scholar 

  77. 77.

    Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Eden, E., Navon, R., Steinfeld, I., Lipson, D. & Yakhini, Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinform. 10, 48 (2009).

    Article  Google Scholar 

  79. 79.

    Rouillard, A. D. et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database 2016, baw100 (2016).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  80. 80.

    Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081–1082 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  81. 81.

    Cheng, W. C. et al. DriverDB: an exome sequencing database for cancer driver gene identification. Nucleic Acids Res. 42, D1048–D1054 (2014).

    CAS  PubMed  Article  Google Scholar 

  82. 82.

    Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291–304 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  83. 83.

    Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408 (2001).

    CAS  Article  Google Scholar 

  84. 84.

    Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

    CAS  Article  Google Scholar 

  85. 85.

    Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  86. 86.

    Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann. Appl. Stat. 10, 946–963 (2016).

    MathSciNet  PubMed  PubMed Central  MATH  Article  Google Scholar 

Download references

Acknowledgements

The authors thank Karin Hönig and Nick Peters for technical assistance. A.D.G. and G.K.M. were supported by grant GR 3924/15-1 from the Deutsche Forschungsgemeinschaft (DFG). D.E.A.-P. and A.D.G. were supported by the Morris Animal Foundation, Grant D14ZO-94. D.E.A.-P. was supported by a postdoctoral fellowship of the Deutscher Akademischer Austauschdienst, Grant 2014 57129705. A.L.R. and A.D.G. were supported by Grant R01GM092706 from the National Institute of General Medical Sciences (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the National Institutes of Health.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Author information

Affiliations

Authors

Contributions

A.D.G. and G.K.M. conceived and designed the study; G.K.M. conceived and performed the analysis; D.E.A.-P. optimised and performed experiments for detecting integration sites; A.D. performed experiments; A.G. carried out koala pathology and sample collection; K.J.C., P.T. and P.R.Y. provided samples; J.H. provided data on koala cancer prevalence; R.T., N.M., M.T. and A.L.R. provided expert opinions, advice and discussions, and contributed to writing of the manuscript; G.K.M., R.T., A.L.R. and A.D.G. wrote the manuscript. All authors reviewed and approved the final version.

Corresponding author

Correspondence to Alex D. Greenwood.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Communications thanks Michael J. Metzger and the other, anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

McEwen, G.K., Alquezar-Planas, D.E., Dayaram, A. et al. Retroviral integrations contribute to elevated host cancer rates during germline invasion. Nat Commun 12, 1316 (2021). https://doi.org/10.1038/s41467-021-21612-7

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing